Rousseau DL, Porto SPS (1970)
The Regulatory Context: What the Industry Landscape Means for Prospective Patients The compounded telehealth GLP-1 industry has faced increasing regulatory attention since 2025, and that trend has only accelerated
In addition to glucagon and GLP-1, glucagon-like peptide-2 (GLP-2), oxyntomodulin, glicentin, glicentin-related pancreatic polypeptide (GRPP), and major proglucagon fragment (MPGF) are synthesized from ProG
* When paired with a balanced diet and regular exercise Linked to better heart health, reduced cholesterol levels, and improved overall metabolic function
In other words, it helps restore the foundation that makes healthy metabolic signaling possible